1. Home
  2. GDS vs BLCO Comparison

GDS vs BLCO Comparison

Compare GDS & BLCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GDS
  • BLCO
  • Stock Information
  • Founded
  • GDS 2001
  • BLCO 1853
  • Country
  • GDS China
  • BLCO Canada
  • Employees
  • GDS N/A
  • BLCO N/A
  • Industry
  • GDS Computer Software: Programming Data Processing
  • BLCO Ophthalmic Goods
  • Sector
  • GDS Technology
  • BLCO Health Care
  • Exchange
  • GDS Nasdaq
  • BLCO Nasdaq
  • Market Cap
  • GDS 4.9B
  • BLCO 4.0B
  • IPO Year
  • GDS 2016
  • BLCO 2022
  • Fundamental
  • Price
  • GDS $21.47
  • BLCO $12.06
  • Analyst Decision
  • GDS Strong Buy
  • BLCO Hold
  • Analyst Count
  • GDS 5
  • BLCO 12
  • Target Price
  • GDS $39.48
  • BLCO $18.64
  • AVG Volume (30 Days)
  • GDS 3.7M
  • BLCO 939.1K
  • Earning Date
  • GDS 05-21-2025
  • BLCO 04-30-2025
  • Dividend Yield
  • GDS N/A
  • BLCO N/A
  • EPS Growth
  • GDS N/A
  • BLCO N/A
  • EPS
  • GDS 2.50
  • BLCO N/A
  • Revenue
  • GDS $1,414,156,264.00
  • BLCO $4,791,000,000.00
  • Revenue This Year
  • GDS $28.60
  • BLCO $6.30
  • Revenue Next Year
  • GDS $10.34
  • BLCO $5.56
  • P/E Ratio
  • GDS $9.04
  • BLCO N/A
  • Revenue Growth
  • GDS 3.67
  • BLCO 15.56
  • 52 Week Low
  • GDS $6.11
  • BLCO $10.46
  • 52 Week High
  • GDS $52.50
  • BLCO $21.69
  • Technical
  • Relative Strength Index (RSI)
  • GDS 39.78
  • BLCO 38.44
  • Support Level
  • GDS $18.09
  • BLCO $11.62
  • Resistance Level
  • GDS $22.08
  • BLCO $12.38
  • Average True Range (ATR)
  • GDS 1.87
  • BLCO 0.89
  • MACD
  • GDS 0.09
  • BLCO -0.03
  • Stochastic Oscillator
  • GDS 46.69
  • BLCO 37.74

About GDS GDS Holdings Limited ADS

GDS Holdings started as an IT service provider in 2001 then moved to the data center business with its first self-developed data center opening in 2010. The company now develops and operates data centers in China and also builds, operates and transfers data centers for other clients. It offers colocation and managed services and mainly targets hyperscale cloud service customers who take large areas of its data centers or even whole data centers under long-term contracts. It has aggressively raised capital over the past four years for expansion. Its data centers are located predominantly in and around the Tier 1 cities in China and it has also started an expanding into Southeast Asia. GDS listed on the Nasdaq in 2016 and completed a secondary listing in Hong Kong in 2020.

About BLCO Bausch + Lomb Corporation

Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.

Share on Social Networks: